{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"2.340","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"1,297,326,429","primaryexch":"香港交易所","ric":"2197.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0,"inline_upper_strike_price":"","sedol":"BP4DDN3","am":"42.73","iv":"","ew_strike":"","as":"2.150","geographic_focus":null,"incorpin":"開曼群島","etp_baseCur":null,"ew_amt_os":"","bd":"2.130","registrar":"香港中央證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"500","update_time":"2025-09-28 00:06:03.0","lo52":"0.185","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"梁朋","underlying_ric":"2197.HK","hi52":"2.450","issuer_name":"三葉草生物製藥有限公司 - B","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"2.060","mkt_cap":"2.76","f_aum_hkd":null,"ew_sub_per_to":"","ls":"2.130","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"-0.130","aum":"","issued_shares_class_B":null,"vo":"19.58","secondary_listing_flag":false,"listing_date":"2021年11月5日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"三葉草生物製藥有限公司 - B","nm_s":"三葉草生物－Ｂ","sym":"2197","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"三葉草生物製藥有限公司是一家主要從事創新型疫苗的研發、生產和商業化的投資控股公司。該公司的產品及候選疫苗包括呼吸道合胞病毒（RSV）疫苗（SCB-1019）、四價季節性流感疫苗AdimFlu-S、SCB-219M、新冠疫苗等。該公司依託Trimer-Tag技術平台開展可解決未滿足需求的創新疫苗的研發（R&D），專注於建立呼吸道疫苗專營權，並在兒科疫苗市場創立業務。Trimer-Tag技術平台是一個基於天然依賴三聚體化功能的靶點用於研製重組蛋白疫苗的產品開發平台。該公司在國內和國外市場開展業務。","op":"2.260","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"生物技術","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"香港銅鑼灣<br/>希慎道33號<br/>利園一期19樓<br/>1901室","pc":"-5.75","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"2.260","isin":"KYG2280A1076","moneyness":""}},"qid":"1759074239199"}
